Dutasterid STADA Capsules, Soft 0.5mg Malta - Ingliż - Medicines Authority

dutasterid stada capsules, soft 0.5mg

stada arzneimittel ag stadastraße 2-18, 61118 bad vilbel, germany - dutasteride - capsule - dutasteride 0.5 mg - urologicals

STADA ANASTROZOLE Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

stada anastrozole

stada pharmaceuticals australia pty ltd - anastrozole -

STADA SILDENAFIL Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

stada sildenafil

stada pharmaceuticals australia pty ltd - sildenafil citrate; sildenafil (as citrate) -

Nintedanib Clonmel 100 mg soft capsules Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

nintedanib clonmel 100 mg soft capsules

clonmel healthcare ltd - nintedanib esylate - capsule, soft - nintedanib

Nintedanib Clonmel 150 mg soft capsules Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

nintedanib clonmel 150 mg soft capsules

clonmel healthcare ltd - nintedanib esylate - capsule, soft - nintedanib

STADA IRBESARTAN HCT 300/25 irbesartan/hydrochlorothiazide 300 mg/25 mg tablet blister Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/25 irbesartan/hydrochlorothiazide 300 mg/25 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; hydrogenated castor oil; microcrystalline cellulose; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium; povidone - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

STADA IRBESARTAN HCT 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; povidone; microcrystalline cellulose; magnesium stearate; hydrogenated castor oil; maize starch; lactose monohydrate - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

STADA IRBESARTAN HCT 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; hydrogenated castor oil; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Pregabalin Clonmel 25 mg capsules, hard Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

pregabalin clonmel 25 mg capsules, hard

clonmel healthcare ltd - pregabalin - capsule, hard - 25 milligram(s) - other antiepileptics; pregabalin

Pregabalin Clonmel 200 mg capsules, hard Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

pregabalin clonmel 200 mg capsules, hard

clonmel healthcare ltd - pregabalin - capsule, hard - 200 milligram(s) - other antiepileptics; pregabalin